Journals / The Journal of Pediatric Research / 2016 / Cilt: 3 - Sayı: 1

Clinical, Laboratory and Molecular Approach to Ten Children with Congenital Neutropenia

Konjenital Nötropenili On Çocukta Klinik, Laboratuvar ve Moleküler İncelemeler Desteğinde Tedavi ve Takibe Yaklaşım

Pages
7–12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The risk of persistence of neutropenia and the chance to reach a genetic diagnosis is higher in neutropenic patients who have accompanying eosinophilia, monocytosis and hypergammaglobulinemia at the time of initial investigation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Severe congenital neutropenia is a rare immunodeficiency disease characterized by lack of mature neutrophils.
📊
Key Findings & Data:We evaluated the association between the molecular, clinical and laboratory findings together with genotype-phenotype relationship in 10 patients with neutropenia.
💡
Conclusion & Impact:Conclusion: The risk of persistence of neutropenia and the chance to reach a genetic diagnosis is higher in neutropenic patients who have accompanying eosinophilia, monocytosis and hypergammaglobulinemia at the time of initial investigation.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Severe congenital neutropenia is a rare immunodeficiency disease characterized by lack of mature neutrophils. We evaluated the association between the molecular, clinical and laboratory findings together with genotype-phenotype relationship in 10 patients with neutropenia. Materials and Methods: The clinical and laboratory findings of ten patients with severe congenital neutropenia were obtained and the diagnosis was confirmed by mutation analysis.Results: The mutation analysis by DNA sequencing revealed HAX-1 mutation in 3 patients from the same family and ELANE/ELA-2 mutation in 1 patient. We compared the patients who had normalization in neutrophil counts and clinical findings spontaneously by age with the patients with HAX1 and ELANE/ELA2 defects and observed that patients with known genetic defects had higher monocyte and immunoglobulin levels on admission. Conclusion: The risk of persistence of neutropenia and the chance to reach a genetic diagnosis is higher in neutropenic patients who have accompanying eosinophilia, monocytosis and hypergammaglobulinemia at the time of initial investigation.

Özet

Amaç: Ağır konjenital nötropeniler, nadir görülen matür nötrofillerin eksikliği ile karakterize immün yetersizlik hastalığıdır. Çalışmamızda amaç Ege Üniversitesi Tıp Fakültesi Pediatrik İmmünoloji Kliniğimizde izlenen ve genetik analiz yapılan 10 nötropeni olgusunun moleküler, klinik ve diğer laboratuvar bulguları ile değerlendirilmesi ve fenotip-genotip ilişkisinin araştırılmasıdır.Gereç ve Yöntemler: Ege Üniversitesi Tıp Fakültesi Pediatrik İmmünoloji Kliniğimizde takip edilen toplam on hastanın klinik, laboratuvar ve tedavi verileri elde edilerek mutasyon analizi yapıldı.Bulgular: Aynı aileden olan üç olguda HAX1 mutasyonu saptanırken, bir olguda ELANE/ELA-2 mutasyonu gösterildi. Yaşla beraber nötrofil sayıları ve klinik bulguları spontan düzelen olgular (n=5) ile genetik olarak doğrulanmış ağır konjenital nötropeni olgularının tanı anında bakılan hemogram ve immunoglobulin değerleri karşılaştırıldığında, düzelmeyen grupta monosit oranı ile IgG/M/A değerlerinin istatistiksel olarak anlamlı yüksek olduğu görüldü.Sonuç: Tanı anında nötropeniye eşlik eden belirgin eosinofili, monositoz ve hipergammaglobulinemi saptanan olgularda nötropenilerinin persiste etme riskinin ve genetik tanıya ulaşabilme şansının daha yüksek olduğu kanısına varılmıştır.

🔖

Cite This Article

EDEER, N. K., AKSU, G., GÜLEZ, N., AZARSIZ, E., KAVAKLI, K., KLEIN, C., KÜTÜKÇÜLER, N. (2016). Clinical, Laboratory and Molecular Approach to Ten Children with Congenital Neutropenia. The Journal of Pediatric Research, Cilt: 3 - Sayı: 1, 7–12. https://ajindex.com/articles/362838

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Dale DC, Bolyard AA, Schwinzer BG, et al. The severe chronic neutropenia international registry: 10-year follow-up report. Support Cancer Ther 2006;3:220-31. Kostmann R. Infantile genetic agranulocytosis: A new recessive lethal disease in man. Acta Paediatr Scand 1956;45:1-78. Klein C. Congenital neutropenia. Hematology Am Soc Hematol Educ Program 2009:344-50.
  2. Klein C, Welte K. Genetic insights into congenital neutropenia. Clin Rev Allergy Immunol 2010;38:68-74.
  3. Donadieu J, Fenneteau O, Beaupain B, Mahlaoui N, Chantelot CB. Congenital neutropenia: Diagnosis, molecular bases and patient management. Orphanet J Rare Dis 2011;6:26. Aksu G, Genel F, Koturoglu G, Kurugöl Z, Kutukculer N. Serum immunoglobulin (IgG, IgM, IgA) and IgG subclass concentrations in healthy children: A study using nephelometric technique. Turk J Pediatr 2006;48:19-24.
  4. Boztug K, Klein C. Genetic etiologies of severe congenital neutropenia. Curr Opin Pediatr 2011;23:21-6.
  5. Dale DC, Person RE, Bolyard AA, et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 2000;96:2317-22.
  6. Horwitz MS, Duan Z, Korkmaz B, et al. Neutrophil elastase in cyclic and severe congenital neutropenia. Blood 2007;109:1817-24.
  7. Smith BN, Ancliff PJ, Pizzey A, et al. Homozygous HAX1 mutations in severe congenital neutropenia patients with sporadic disease: A novel mutation in two unrelated British kindreds. Br J Haematol 2009;144:762-70.
  8. Rezaei N, Moin M, Pourpak Z, et al. The clinical, immunohematological, and molecular study of Iranian patients with severe congenital neutropenia. J Clin Immunol 2007;27:525-33.
  9. Klein C, GrudzienM, Appaswamy G, et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet 2007;39:86-92.
  10. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiency). Clin Immunol 1999;93:190-7.
  11. Zeidler C, Germeshausen M, Klein C, Welte K. Clinical implications of ELA2-, HAX1-, and G-CSF-receptor (CSF3R) mutations in severe congenital neutropenia. Br J Haematol 2009;144:459-67.
  12. Boztug K, Appaswamy G, Ashikov A, et al. A syndrome with congenital neutropenia and mutations in G6PC3. N Engl J Med 2009;360:32-43.